Merck
MRK
#64
Rank
$242.01 B
Marketcap
$96.89
Share price
-2.06%
Change (1 day)
-4.14%
Change (1 year)

Merck (MRK) - Total assets

Total assets on the balance sheet as of September 2025 : $129.54 Billion USD

According to Merck's latest financial reports the company's total assets are $129.54 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Merck - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31$117.10 B9.78%
2023-12-31$106.67 B-2.28%
2022-12-31$109.16 B3.28%
2021-12-31$105.69 B15.4%
2020-12-31$91.58 B8.52%
2019-12-31$84.39 B2.13%
2018-12-31$82.63 B-5.96%
2017-12-31$87.87 B-7.87%
2016-12-31$95.37 B-6.2%
2015-12-31$101.67 B3.58%
2014-12-31$98.16 B-7.08%
2013-12-31$105.64 B-0.46%
2012-12-31$106.13 B0.96%
2011-12-31$105.12 B-0.62%
2010-12-31$105.78 B-5.82%
2009-12-31$112.31 B137.98%
2008-12-31$47.19 B-2.39%
2007-12-31$48.35 B8.48%
2006-12-31$44.56 B-0.62%
2005-12-31$44.84 B5.34%
2004-12-31$42.57 B4.89%
2003-12-31$40.58 B-14.66%
2002-12-31$47.56 B8.04%
2001-12-31$44.02 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
$208.73 B 61.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$192.81 B 48.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$114.93 B-11.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$96.88 B-25.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$152.32 B 17.58%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
$82.46 B-36.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
$39.85 B-69.23%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
$107.28 B-17.18%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Abbott Laboratories
ABT
$84.18 B-35.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$90.14 B-30.42%๐Ÿ‡บ๐Ÿ‡ธ USA